Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank20
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-15.88
↓ 69% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
-9.40
Historical baseline
PeriodValueYoY Change
2025-15.88-372.4%
2024-3.36+22.4%
2023-4.33-35.4%
2022-3.20+32.5%
2021-4.74+81.0%
2020-24.92-